Reference
Lupascu A, et al. The frequency of adverse events during anti-TNF therapy in patients with inflammatory bowel disease. Journal of Gastrointestinal and Liver Diseases 27 (Suppl. 3): 13-14 abstr. 26, Sep 2018. Available from: URL: https://www.jgld.ro/jgld/public/public/Supplements/supplement_2018_3.pdf [abstract]
Rights and permissions
About this article
Cite this article
Adalimumab. Reactions Weekly 1818, 15 (2020). https://doi.org/10.1007/s40278-020-82295-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-020-82295-2